CluePoints
acquired by Eqt3 known investors
CluePoints provides a Risk-Based Quality Management (RBQM) and clinical data review platform for pharmaceutical Sponsors and CROs, combining centralized risk detection, site-level action, medical coding, safety review, and query detection in a single ICH E6(R3)-aligned system. The platform serves large pharma, mid-market sponsors, and CROs running clinical trials.
AI & Machine LearningHealthtechSaaS
Investors · 3
Frequently asked questions
- What does CluePoints do?
- CluePoints provides a Risk-Based Quality Management (RBQM) and clinical data review platform for pharmaceutical Sponsors and CROs, combining centralized risk detection, site-level action, medical coding, safety review, and query detection in a single ICH E6(R3)-aligned system. The platform serves large pharma, mid-market sponsors, and CROs running clinical trials.
- Who are CluePoints's investors?
- CluePoints's investors include Nivelinvest, Seido Capital, Summit Partners.
- Who acquired CluePoints?
- CluePoints was acquired by Eqt.